Cargando…
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous neoplasm of the bone marrow with poor prognosis. In clinical practice new prognostic factors are still needed. MicroRNAs (miRs), small endogenous noncoding RNAs, play an essential role in the development and progression of acute leukemia. T...
Autores principales: | Butrym, Aleksandra, Rybka, Justyna, Baczyńska, Dagmara, Tukiendorf, Andrzej, Kuliczkowski, Kazimierz, Mazur, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508825/ https://www.ncbi.nlm.nih.gov/pubmed/26126974 http://dx.doi.org/10.1186/s13046-015-0184-z |
Ejemplares similares
-
Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2016) -
Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018) -
Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2016) -
High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients
por: Butrym, Aleksandra, et al.
Publicado: (2013) -
The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy
por: Rybka, Justyna, et al.
Publicado: (2014)